Queensland COVID-19 Vaccination (QoVAX) Safety and Efficacy Trial Pilot Study in adults aged 18 years and over [Dataset]

The QoVax SET research pilot study is designed to investigate intrinsic and extrinsic host and viral determinants of vaccine safety, immunity and efficacy in Queensland. Specifically, the QoVax SET Program seeks to determine whether the vaccines administered by Queensland Health facilities are safe and effective in the Queensland community to: Induce SARS-CoV2 immunity; Limit the severity of virus-induced disease, and; Sustain immunity and protection from SARS-CoV2 disease in QLD.

QoVax SET研究试点项目旨在探究昆士兰州内，与疫苗安全性、免疫应答及保护效力相关的宿主内在、外在因素及病毒相关决定因素。具体而言，QoVax SET项目旨在明确昆士兰州卫生机构所接种的疫苗，在昆士兰社区中是否能够实现以下目标：诱导严重急性呼吸综合征冠状病毒2（SARS-CoV-2）免疫应答；降低病毒感染引发的疾病严重程度；以及维持昆士兰州境内针对严重急性呼吸综合征冠状病毒2感染相关疾病的免疫保护效果。